Clinical Trial Update: The Effect of Co-enzyme Q10 on the Clinical Outcome of Pediatric Patients With Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial investigated the effect of Coenzyme Q10 on clinical outcomes in pediatric patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Ain Shams University | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED